{"id":"https://openalex.org/W2004237531","doi":"https://doi.org/10.1111/j.1574-695x.1998.tb01161.x","title":"Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis","display_name":"Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis","alternate_titles":[],"publication_year":1998,"publication_date":"1998-06-01","ids":{"openalex":"https://openalex.org/W2004237531","doi":"https://doi.org/10.1111/j.1574-695x.1998.tb01161.x","mag":"2004237531","pmid":"https://pubmed.ncbi.nlm.nih.gov/9685005"},"language":"en","primary_location":{"id":"doi:10.1111/j.1574-695x.1998.tb01161.x","doi":"https://doi.org/10.1111/j.1574-695x.1998.tb01161.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1574-695x.1998.tb01161.x","pdf_url":null,"source":{"id":"https://openalex.org/S136462399","display_name":"FEMS Immunology & Medical Microbiology","issn_l":"0928-8244","issn":["0928-8244","1574-695X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FEMS Immunology &amp; Medical Microbiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2004237531"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/femspd/article-pdf/21/2/149/19163169/21-2-149.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051476552","display_name":"Nalin Rastogi","orcid":"https://orcid.org/0000-0002-7199-7747","observed_orcids":["https://orcid.org/0000-0002-7199-7747"]},"institutions":[{"id":"https://openalex.org/I157536573","display_name":"Institut Pasteur","ror":"https://ror.org/0495fxg12","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I157536573"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nalin Rastogi","raw_affiliation_strings":["Unit\u00e9 de la Tuberculose et des Mycobact\u00e9ries, Institut Pasteur, Pointe \u00e0 Pitre, Guadeloupe. rastogi@ipagua.gp","Unit\u00e9 de la Tuberculose et des Mycobact\u00e9ries, Institut Pasteur, P.O. Box 484, 97165-Pointe \u00e0 Pitre Cedex, Guadeloupe"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 de la Tuberculose et des Mycobact\u00e9ries, Institut Pasteur, Pointe \u00e0 Pitre, Guadeloupe. rastogi@ipagua.gp","institution_ids":["https://openalex.org/I157536573"]},{"raw_affiliation_string":"Unit\u00e9 de la Tuberculose et des Mycobact\u00e9ries, Institut Pasteur, P.O. Box 484, 97165-Pointe \u00e0 Pitre Cedex, Guadeloupe","institution_ids":["https://openalex.org/I157536573"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111951856","display_name":"Khye Seng Goh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157536573","display_name":"Institut Pasteur","ror":"https://ror.org/0495fxg12","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I157536573"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Khye Seng Goh","raw_affiliation_strings":["Unit\u00e9 de la Tuberculose et des Mycobact\u00e9ries, Institut Pasteur, P.O. Box 484, 97165-Pointe \u00e0 Pitre Cedex, Guadeloupe"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 de la Tuberculose et des Mycobact\u00e9ries, Institut Pasteur, P.O. Box 484, 97165-Pointe \u00e0 Pitre Cedex, Guadeloupe","institution_ids":["https://openalex.org/I157536573"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014226002","display_name":"Lionel Horgen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157536573","display_name":"Institut Pasteur","ror":"https://ror.org/0495fxg12","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I157536573"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lionel Horgen","raw_affiliation_strings":["Unit\u00e9 de la Tuberculose et des Mycobact\u00e9ries, Institut Pasteur, P.O. Box 484, 97165-Pointe \u00e0 Pitre Cedex, Guadeloupe"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 de la Tuberculose et des Mycobact\u00e9ries, Institut Pasteur, P.O. Box 484, 97165-Pointe \u00e0 Pitre Cedex, Guadeloupe","institution_ids":["https://openalex.org/I157536573"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090622786","display_name":"William W. Barrow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108109523","display_name":"Southern Research Institute","ror":"https://ror.org/0153ngy95","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I108109523"]},{"id":"https://openalex.org/I157536573","display_name":"Institut Pasteur","ror":"https://ror.org/0495fxg12","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I157536573"]}],"countries":["FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William W Barrow","raw_affiliation_strings":["Mycobacteriology Research Unit, Southern Research Institute, Birmingham, AL 35205, USA","Unit\u00e9 de la Tuberculose et des Mycobact\u00e9ries, Institut Pasteur, P.O. Box 484, 97165-Pointe \u00e0 Pitre Cedex, Guadeloupe"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mycobacteriology Research Unit, Southern Research Institute, Birmingham, AL 35205, USA","institution_ids":["https://openalex.org/I108109523"]},{"raw_affiliation_string":"Unit\u00e9 de la Tuberculose et des Mycobact\u00e9ries, Institut Pasteur, P.O. Box 484, 97165-Pointe \u00e0 Pitre Cedex, Guadeloupe","institution_ids":["https://openalex.org/I157536573"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5051476552"],"corresponding_institution_ids":["https://openalex.org/I157536573"],"apc_list":null,"apc_paid":null,"fwci":0.6884,"has_fulltext":true,"cited_by_count":104,"citation_normalized_percentile":{"value":0.70439602,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"21","issue":"2","first_page":"149","last_page":"157"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mycobacterium-tuberculosis","display_name":"Mycobacterium tuberculosis","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cerulenin","display_name":"cerulenin","score":0.7639999985694885},{"id":"https://openalex.org/keywords/trans-cinnamic-acid","display_name":"trans-cinnamic acid","score":1.0},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7609999775886536},{"id":"https://openalex.org/keywords/antituberculosis-drugs","display_name":"antitubercular agents","score":0.8840000033378601},{"id":"https://openalex.org/keywords/ethambutol","display_name":"ethambutol","score":0.9190000295639038},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.9240000247955322},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.996999979019165},{"id":"https://openalex.org/keywords/ofloxacin","display_name":"ofloxacin","score":0.9890000224113464},{"id":"https://openalex.org/keywords/amikacin","display_name":"amikacin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/clofazimine","display_name":"clofazimine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8220000267028809}],"concepts":[{"id":"https://openalex.org/C2776228421","wikidata":"https://www.wikidata.org/wiki/Q412318","display_name":"Ethambutol","level":4,"score":0.8923206925392151},{"id":"https://openalex.org/C2776297342","wikidata":"https://www.wikidata.org/wiki/Q418611","display_name":"Clofazimine","level":3,"score":0.8155379891395569},{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.7061888575553894},{"id":"https://openalex.org/C2776967927","wikidata":"https://www.wikidata.org/wiki/Q423169","display_name":"Isoniazid","level":3,"score":0.665429413318634},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.6608263254165649},{"id":"https://openalex.org/C2780683386","wikidata":"https://www.wikidata.org/wiki/Q5065296","display_name":"Cerulenin","level":4,"score":0.5540769696235657},{"id":"https://openalex.org/C2780459521","wikidata":"https://www.wikidata.org/wiki/Q417571","display_name":"Pyrazinamide","level":4,"score":0.546514093875885},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.519275426864624},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5153195858001709},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5076953172683716},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.4907110929489136},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4739950895309448},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.4413837790489197},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.37504079937934875},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28009188175201416},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1941508948802948},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1085469126701355},{"id":"https://openalex.org/C2780695269","wikidata":"https://www.wikidata.org/wiki/Q36956","display_name":"Leprosy","level":2,"score":0.07710036635398865},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.04539021849632263},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C48289651","wikidata":"https://www.wikidata.org/wiki/Q106916817","display_name":"Fatty acid synthase","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000904","descriptor_name":"Antibiotics, Antitubercular","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002569","descriptor_name":"Cerulenin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002934","descriptor_name":"Cinnamates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004977","descriptor_name":"Ethambutol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009169","descriptor_name":"Mycobacterium tuberculosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015169","descriptor_name":"Colony Count, Microbial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018088","descriptor_name":"Tuberculosis, Multidrug-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1574-695x.1998.tb01161.x","doi":"https://doi.org/10.1111/j.1574-695x.1998.tb01161.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1574-695x.1998.tb01161.x","pdf_url":null,"source":{"id":"https://openalex.org/S136462399","display_name":"FEMS Immunology & Medical Microbiology","issn_l":"0928-8244","issn":["0928-8244","1574-695X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FEMS Immunology &amp; Medical Microbiology","raw_type":"journal-article"},{"id":"doi:10.1016/s0928-8244(98)00044-3","doi":"https://doi.org/10.1016/s0928-8244(98)00044-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0928-8244(98)00044-3","pdf_url":"https://academic.oup.com/femspd/article-pdf/21/2/149/19163169/21-2-149.pdf","source":{"id":"https://openalex.org/S136462399","display_name":"FEMS Immunology & Medical Microbiology","issn_l":"0928-8244","issn":["0928-8244","1574-695X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FEMS Immunology and Medical Microbiology","raw_type":"journal-article"},{"id":"pmid:9685005","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9685005","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FEMS immunology and medical microbiology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:pasteur-00931156v1","doi":null,"is_oa":false,"landing_page_url":"https://riip.hal.science/pasteur-00931156","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"FEMS Immunology and Medical Microbiology, 1998, 21 (2), pp.149-157. &#x27E8;10.1111/j.1574-695X.1998.tb01161.x&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/s0928-8244(98)00044-3","doi":"https://doi.org/10.1016/s0928-8244(98)00044-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0928-8244(98)00044-3","pdf_url":"https://academic.oup.com/femspd/article-pdf/21/2/149/19163169/21-2-149.pdf","source":{"id":"https://openalex.org/S136462399","display_name":"FEMS Immunology & Medical Microbiology","issn_l":"0928-8244","issn":["0928-8244","1574-695X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FEMS Immunology and Medical Microbiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1047222286","display_name":"PROCESSING OF AIDS RELATED MYCOBACTERIAL ANTIGENS","funder_award_id":"R01AI021946","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G125933285","display_name":"CONTINUING STUDY ON AIDS-RELATED OPPORTUNISTIC PATHOGENS","funder_award_id":"R03TW000533","funder_id":"https://openalex.org/F4320337356","funder_display_name":"Fogarty International Center"},{"id":"https://openalex.org/G4947329905","display_name":null,"funder_award_id":"TWOO533","funder_id":"https://openalex.org/F4320337356","funder_display_name":"Fogarty International Center"},{"id":"https://openalex.org/G8497237331","display_name":"GLYCOPEPTIDOLIPID BIOSYNTHESIS IN AVIUM COMPLEX","funder_award_id":"R01AI030088","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320330229","display_name":"Fondation Raoul Follereau","ror":"https://ror.org/05pyqq171"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337356","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2004237531.pdf","grobid_xml":"https://content.openalex.org/works/W2004237531.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W180254789","https://openalex.org/W1599735915","https://openalex.org/W1919928987","https://openalex.org/W1966719805","https://openalex.org/W1968104649","https://openalex.org/W1972770301","https://openalex.org/W1990878558","https://openalex.org/W1991809257","https://openalex.org/W1993666775","https://openalex.org/W2005968905","https://openalex.org/W2008512452","https://openalex.org/W2009290349","https://openalex.org/W2011929499","https://openalex.org/W2027102095","https://openalex.org/W2028861996","https://openalex.org/W2042140860","https://openalex.org/W2051266658","https://openalex.org/W2052077146","https://openalex.org/W2052355119","https://openalex.org/W2070783522","https://openalex.org/W2079789539","https://openalex.org/W2081946274","https://openalex.org/W2088653525","https://openalex.org/W2091532890","https://openalex.org/W2092376949","https://openalex.org/W2098286022","https://openalex.org/W2099030775","https://openalex.org/W2099617791","https://openalex.org/W2127689664","https://openalex.org/W2128811343","https://openalex.org/W2137386154","https://openalex.org/W2138127072","https://openalex.org/W2144345256","https://openalex.org/W2146714388","https://openalex.org/W2338213273","https://openalex.org/W2400305971","https://openalex.org/W2418320700","https://openalex.org/W2999920649","https://openalex.org/W3112434901","https://openalex.org/W3140733006"],"related_works":["https://openalex.org/W2022538033","https://openalex.org/W2099030775","https://openalex.org/W2551429320","https://openalex.org/W2006556939","https://openalex.org/W2557212878","https://openalex.org/W2934791552","https://openalex.org/W2178981763","https://openalex.org/W4286229658","https://openalex.org/W3129318754","https://openalex.org/W7157576969"],"abstract_inverted_index":{"The":[0,83,102],"recent":[1],"upsurge":[2],"in":[3,98,108,111,128],"the":[4,17,26,30,39,55,71],"incidence":[5],"of":[6,11,19,32,57,73,138,143,146],"tuberculosis":[7],"with":[8,88,134],"significant":[9],"emergence":[10],"multidrug-resistant":[12],"cases":[13],"has":[14],"focused":[15],"on":[16,25],"priority":[18],"discovering":[20],"effective":[21,151],"new":[22],"drugs":[23,34],"and":[24,45,78,121,141],"strategies":[27],"to":[28,53,69,117,153],"augment":[29,54],"potential":[31],"existing":[33],"against":[35,60,80],"Mycobacterium":[36,61],"tuberculosis.":[37,82],"In":[38],"present":[40],"study,":[41],"we":[42],"investigated":[43],"cerulenin":[44,120],"trans-cinnamic":[46,124],"acid,":[47],"which":[48],"have":[49],"recently":[50],"been":[51],"shown":[52],"activity":[56,72,110,130],"various":[58],"antibiotics":[59],"avium":[62],"[Antimicrob.":[63],"Agents":[64],"Chemother.":[65],"38":[66],"(1994)":[67],"2287-2295],":[68],"enhance":[70],"isoniazid,":[74],"rifampin,":[75],"ofloxacin,":[76],"amikacin":[77],"clofazimine":[79],"M.":[81],"synergy":[84],"observed":[85,133],"was":[86,131],"compared":[87,116],"identical":[89],"combinations":[90],"using":[91],"ethambutol,":[92],"a":[93],"cell":[94],"wall-inhibiting":[95],"drug":[96,113,129,160],"used":[97],"standard":[99],"antituberculous":[100],"chemotherapy.":[101],"results":[103],"showed":[104],"that":[105],"ethambutol":[106],"resulted":[107],"synergistic":[109],"12/30":[112],"combinations,":[114],"as":[115],"15/36":[118],"for":[119,123,158],"101/18":[122],"acid.":[125],"This":[126],"increase":[127],"even":[132],"drug-resistant":[135],"isolates.":[136],"Use":[137],"novel":[139],"antimicrobials":[140],"understanding":[142],"their":[144],"mechanisms":[145],"action":[147],"may":[148],"be":[149],"an":[150],"strategy":[152],"determine":[154],"previously":[155],"undescribed":[156],"targets":[157],"future":[159],"development.":[161]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2004237531","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
